Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP412516.RAN9CcM1Q2F-3oEapc1fXMQYEnfVx56OAPCCsda1OS_9s130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP412516.RAN9CcM1Q2F-3oEapc1fXMQYEnfVx56OAPCCsda1OS_9s130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP412516.RAN9CcM1Q2F-3oEapc1fXMQYEnfVx56OAPCCsda1OS_9s130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP412516.RAN9CcM1Q2F-3oEapc1fXMQYEnfVx56OAPCCsda1OS_9s130_provenance.
- NP412516.RAN9CcM1Q2F-3oEapc1fXMQYEnfVx56OAPCCsda1OS_9s130_assertion description "[These results validate myostatin inhibition as a therapeutic approach to muscle wasting diseases such as muscular dystrophy, sarcopenic frailty of the elderly and amylotrophic lateral sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP412516.RAN9CcM1Q2F-3oEapc1fXMQYEnfVx56OAPCCsda1OS_9s130_provenance.
- NP412516.RAN9CcM1Q2F-3oEapc1fXMQYEnfVx56OAPCCsda1OS_9s130_assertion evidence source_evidence_literature NP412516.RAN9CcM1Q2F-3oEapc1fXMQYEnfVx56OAPCCsda1OS_9s130_provenance.
- NP412516.RAN9CcM1Q2F-3oEapc1fXMQYEnfVx56OAPCCsda1OS_9s130_assertion SIO_000772 16246158 NP412516.RAN9CcM1Q2F-3oEapc1fXMQYEnfVx56OAPCCsda1OS_9s130_provenance.
- NP412516.RAN9CcM1Q2F-3oEapc1fXMQYEnfVx56OAPCCsda1OS_9s130_assertion wasDerivedFrom befree-20140225 NP412516.RAN9CcM1Q2F-3oEapc1fXMQYEnfVx56OAPCCsda1OS_9s130_provenance.
- NP412516.RAN9CcM1Q2F-3oEapc1fXMQYEnfVx56OAPCCsda1OS_9s130_assertion wasGeneratedBy ECO_0000203 NP412516.RAN9CcM1Q2F-3oEapc1fXMQYEnfVx56OAPCCsda1OS_9s130_provenance.
- befree-20140225 importedOn "2014-02-25" NP412516.RAN9CcM1Q2F-3oEapc1fXMQYEnfVx56OAPCCsda1OS_9s130_provenance.